Caas Capital Management LP Galera Therapeutics, Inc. Transaction History

Caas Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.08 - $10.44 $1.66 Million - $2.85 Million	-273,210 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $793,826 - $1.18 Million	95,069 Added 53.37%	273,210 $2.41 Million
Q4 2020 Feb 12, 2021	BUY	$8.02 - $12.81 $1.43 Million - $2.28 Million	178,141 New	178,141 $1.82 Million

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.